drugset
drugset / Trial / NCT02466750

Safety and Immunogenicity Study of the Western Equine Encephalitis (WEE) Vaccine

NCT02466750 ↗

Phase 2 Unknown 500 enrolled U.S. Army Medical Research and Development Command
Non-randomizedParallel-groupOpen-labelPrevention

Summary

This study is being conducted to collect safety and immunogenicity data for the WEE vaccine, TSI-GSD 210. Enrollment in this protocol is offered for personnel who enter areas where this virus is used in research or is endemic (an area where this disease process is found to occur frequently).

Timeline

Start
2015-12-15
Primary completion
2021-06
Completion
2021-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Western Equine Encephalitis (WEE) Vaccine Vaccine — —

Indications

western equine encephalitis